Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
News May 10, 2013
Agilent Technologies Inc. announced the winner of the fifth annual Agilent Early Career Professor Award: Dr. Jindan Yu, assistant professor of medicine at Northwestern University in Evanston, Ill., who will direct $100,000 in unrestricted research funding from Agilent.
Yu joined the faculty in the department of medicine at Northwestern University in 2009. Her research uses genomics and bioinformatics to better understand the progression of prostate cancer. Her aim is to develop novel prognostic/diagnostic tools and treatment strategies.
This year’s award focused on cancer diagnostics, a field of increasing importance to Agilent, which acquired Dako, a worldwide provider of cancer diagnostics, in June.
To qualify for the award, a professor must make significant contributions to the subset of cancer diagnostics aimed at multi-analyte tools for proteomic and/or genomic biomarkers in pathology. Yu has discovered several biomarkers associated with prostate cancer.
“It’s always a great honor to have the work of a faculty member recognized, especially early in her career,” said Jay Walsh, vice president for research at Northwestern University. “The Office for Research congratulates Dr. Yu and thanks Agilent Technologies for awarding her this recognition.”
“We recognize Dr. Yu for her original and important results in cancer genomics and bioinformatics, and we are looking forward to following her future research in cancer diagnostics,” said Jack Wenstrand, director of university relations and external research at Agilent. “Our global call for nominations resulted in a remarkable pool of finalists, and we congratulate Dr. Yu, winner of this competitive award.”
The Agilent Early Career Professor Award is presented annually to recognize and encourage excellence in measurement research. It seeks to establish strong collaborative relationships between Agilent researchers and leading professors early in their careers, as well as to underscore Agilent’s role as a sponsor of university research.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Comments | 0 ADD COMMENT
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018